Share Twitter LinkedIn Facebook Email Ajay K. Nooka, MD of @WinshipAtEmory discusses multiple myeloma disparities.
Teclistamab FDA Approval Biweekly Dosing Multiple Myeloma [3 KOL Interviews] Multiple Myeloma 13 Mins Read